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Abstract
Intracellular Ca2z dynamics of airway smooth muscle cells (ASMC) mediate ASMC contraction and proliferation, and thus
play a key role in airway hyper-responsiveness (AHR) and remodelling in asthma. We evaluate the importance of store-
operated Ca2z entry (SOCE) in these Ca2z dynamics by constructing a mathematical model of ASMC Ca2z signaling based
on experimental data from lung slices. The model confirms that SOCE is elicited upon sufficient Ca2z depletion of the
sarcoplasmic reticulum (SR), while receptor-operated Ca2z entry (ROCE) is inhibited in such conditions. It also shows that
SOCE can sustain agonist-induced Ca2z oscillations in the absence of other Ca2z influx. SOCE up-regulation may thus
contribute to AHR by increasing the Ca2z oscillation frequency that in turn regulates ASMC contraction. The model also
provides an explanation for the failure of the SERCA pump blocker CPA to clamp the cytosolic ½Ca2z of ASMC in lung slices,
by showing that CPA is unable to maintain the SR empty of Ca2z. This prediction is confirmed by experimental data from
mouse lung slices, and strongly suggests that CPA only partially inhibits SERCA in ASMC.
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Introduction
Ca2z is a ubiquitous cellular messenger, controlling a wide
range of biological functions. These include ASMC contraction
and proliferation, which are associated with airway hyper-
responsiveness (enhanced contractility) and airway remodelling
(structural changes) in asthma. The main trigger for cytoplasmic
Ca2z (½Ca2zi) increase in ASMC is agonist stimulation at the cell
membrane (e.g., by histamine released from mast cells or
acethylcholine released from nerves). Binding of agonist to G-
protein coupled receptors induces the production of IP3, a second
messenger which diffuses into the cytosol and binds to IP3 receptor
Ca2z channels (IPR) on the sarcoplasmic reticulum (SR)
membrane (Fig. 1). This causes the IPR to open and release
Ca2z from the SR into the cytosol (the SR being the main Ca2z
store in ASMC). As ½Ca2zi exerts a positive feedback on IPR, this
results in so-called Ca2z -induced Ca2z release (CICR). The
release is terminated by the inhibition of the IPR at large ½Ca2zi,
and Ca2z is pumped back into the SR by Ca2z ATP-ases
(SERCA). Hence, for sufficient IP3 concentration, cycling of Ca
2z
through IPR can occur, and give rise to the repetitive propagation
of ½Ca2zi waves through the cytosol. These appear as ½Ca2zi
oscillations at the whole-cell level. Importantly, airway contraction
increases with the frequency of these ½Ca2zi oscillations [1,2].
Ca2z dynamics are also involved in ASMC proliferation [3–5],
and in the assembly of myosin thick filament and actin thin
filament [6–8], which form the contractile machinery of ASMC.
In addition, several Ca2z channels and pumps in ASMC are
regulated by inflammatory mediators present in asthma (e.g., [4,9–
12]). Ca2z dynamics therefore appear to be involved in multiple
interrelated aspects of asthma at the cellular level. In the present
work, we use mathematical modelling to investigate the important
Ca2z pathways at play in Ca2z dynamics of ASMC and thus
improve our understanding of airway hyper-responsiveness and
remodelling in asthma.
Store-operated Ca2z entry (SOCE) is one important Ca2z
entry mechanism, in which plasma membrane (PM) Ca2z
channels open in response to Ca2z store depletion. These are
called store-operated Ca2z channels (SOCC). Although the
concept of SOCE was proposed 25 years ago [13], the mechanism
of its activation has been identified only recently [14]. The process
is mediated by stromal interaction molecules (STIM), proteins
embedded in the SR membrane which are sensitive to SR Ca2z.
Upon dissociation of Ca2z from their SR binding site, they
oligomerise and translocate within the SR membrane to the
plasma membrane. Here, STIM proteins bind to Orai and/or
TRP, the proteins forming the pore of SOCC, and trigger their
opening (Fig. 1). Although SOCE has been identified in many
cells, it is generally stimulated by artificial emptying of the Ca2z
store, as there is unfortunately no specific pharmacological SOCC
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blocker. Hence, the importance of store depletion, and therefore of
SOCE, during physiological conditions such as Ca2z oscillations,
remains largely unknown. This may explain why SOCE has been
included only in a few mathematical models of Ca2z dynamics
[15–18]. In particular, no prior modelling work on Ca2z
dynamics in ASMC [19–23] has taken SOCE into account, even
though there is evidence that SOCE is up-regulated by
inflammatory mediators found in asthma (TNF-a and IL-13)
[9,11,24], and is associated with ASMC proliferation [3,5].
In this paper, we develop a mathematical model to evaluate the
importance of SOCE in Ca2z dynamics of ASMC. While there is
much evidence that SOCE occurs upon SR depletion in cultured
ASMC in vitro (e.g., [3,25–27]), these cultured cells often lose their
contractile phenotype, and rarely display agonist-induced Ca2z
oscillations. Hence, ASMC in lung slices, which retain most of their
physiological and morphological characteristics, are a more reliable
preparation to study ASMC ½Ca2zi dynamics. Moreover, the
available data from lung slices reflect ½Ca2zi dynamics in individual
ASMC, while the majority of works with cultured cells provide only
global imaging of ½Ca2zi over wells containing thousands of
ASMC. Therefore, we base our model on data from lung slices.
SOCE has not been studied directly in lung slices, but a treatment
with ryanodine-caffeine (Rya-Caf) has previously been used to clamp
the cytosolic Ca2z of ASMC [2,28,29], which relies on emptying the
SR from Ca2z. The results of these experiments therefore provide
invaluable information about SOCE. Because agonist stimulation
was systematically performed before Rya-Caf treatment to ensure
that the lung slice is viable, i.e., that ASMC exhibit normal ½Ca2zi
oscillations and contraction, we can construct a mathematical model
of ½Ca2zi dynamics informed by these data that accounts for both
physiological and non-physiological conditions. The model is then
used to i) evaluate the effect of SOCE up- and down-regulation on
agonist-induced ½Ca2zi oscillations, and (ii) explain the inability of
the SERCA pump blocker CPA to clamp the ½Ca2zi, in contrast
with Rya-Caf treatment.
Methods
Ethics Statement
The experimental study followed the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health. The protocol was approved by the
Institutional Animal Care Committee of the University of
Massachusetts Medical School (Docket Number: A-836–12).
Animals were euthanized with sodium pentobarbital before tissue
collection.
Experimental data
Data consist of fluorescence recordings of ½Ca2zi dynamics in
ASMC within intact lung slices. All the materials and methods
have been previously described (e.g., [2,28]). Essentially, ½Ca2zi
imaging was performed from regions of about 4mm2 within ASMC
(Fig. 2), using two-photon laser scanning microscopy. The
fluorescent indicator employed was Oregon Green BAPTA-1-
AM, which has a high affinity for Ca2z (Kd^0:2mM). We use
published data [2] to develop the mathematical model, and new
experimental results to test the model predictions (see Results).
The latter data can be made freely available upon request for
academic, non-commercial use.
Mathematical model
Intracellular Ca2z dynamics are modelled at the whole-cell
level, via the following system of ordinary differential equations
(e.g., [30]):
dc
dt
~Jin{JPMCAzJrel{JSERCA,
dcs
dt
~c(JSERCA{Jrel),
ð1Þ
where c~ ½Ca2zi is the free cytosolic Ca2z concentration, and
cs~ ½Ca2zSR is the free SR Ca2z concentration.
The term Jin represents the total influx of Ca
2z into the cytosol
through PM channels; JPMCA, the Ca
2z efflux through the PM
Ca2z ATP-ase pumps (PMCA); Jrel , the Ca
2z flux of Ca2z from
the SR into the cytosol, and JSERCA, the flux of Ca
2z from the
cytosol into the SR through the SR/ER Ca2z ATP-ases
Figure 1. Schematic of Ca2z signalling in ASMC. Agonist
stimulation of G-protein coupled receptors (GPCR) induces PLCb
activation, giving rise to IP3 production and Ca
2z entry through
receptor-operated Ca2z channels (ROCC). IP3 triggers Ca
2z release
through IPR. Depletion of the SR from Ca2z causes STIM protein
oligomerisation and migration toward the cell membrane, where they
bind and activate store-operated Ca2z channels (SOCC). Ca2z ATP-
ases pump Ca2z back into the SR (SERCA) and out of the cell (PMCA).
doi:10.1371/journal.pone.0069598.g001
Figure 2. Fluorescence image of part of a mouse airway wall
obtained by two-photon laser scanning microscopy. The yellow
square shows a typical region, within an ASMC, from which Ca2z
dynamics is imaged.
doi:10.1371/journal.pone.0069598.g002
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(SERCA). The factor c represents the ratio of cytoplasmic volume
to SR volume, and implicitly incorporates the relative effect of fast,
linear (e.g., low affinity) Ca2z buffers in the SR compared to the
effect of similar buffers in the cytosol. Indeed, the effect of fast,
linear buffers amounts to a global rescaling of the Ca2z fluxes in
the corresponding compartment (e.g., [30]). The other buffers are
assumed to have a negligible effect on Ca2z dynamics at the
whole-cell level (see also Discussion).
We assume that
Jin~JleakinzJROCCzJSOCC , ð2Þ
where Jleakin is a constant Ca
2z leak through unspecified
channels, JROCC is the Ca
2z influx through receptor-operated
Ca2z channels (ROCC) and JSOCC the influx through SOCC. We
neglect the Ca2z influx through voltage-operated Ca2z channels
(VOCC) because membrane depolarisation plays little role during
agonist-induced ½Ca2zi signalling and contraction in ASMC (in
contrast to other types of muscle cells, including vascular smooth
muscle cells, where action potentials are crucial to contraction)
[1,31]. The Ca2z influxes are modelled by:
Jleakin~a0, ð3aÞ
JROCC~a1p, ð3bÞ
JSOCC(Pso)~VsPso: ð3cÞ
where a0 and a1 are constants, p is the agonist concentration, Vs is
the maximum SOCC flux, and Pso represents the fraction of
STIM proteins bound to Orai/TRP proteins, i.e. the fraction of
activated SOCC. This fraction adapts slowly to changes in cs,
because the diffusion of STIM within the SR membrane is a slow
process [32]. We model this phenomenologically by
dPso
dt
~ P?so (cs){Pso
 
=ts, ð4aÞ
P?so (cs)~
K4s
K4szc
4
s
: ð4bÞ
The steady-state function P?so can be interpreted as the fraction
of STIM proteins dissociated from SR Ca2z (as a consequence of
store depletion), and thus able to oligomerise and move toward the
PM to bind with Orai and/or TRP (see also Discussion). P?so is
therefore a decreasing function of ½Ca2zSR, which we model by
the reverse Hill function Eq. (0b), assuming affinity Ks for
½Ca2zSR and Hill coefficient ns~4 [33].
The total Ca2z flux from the SR into the cytosol is given by
Jrel~JIPRzJRyRzJleakSR, ð8Þ
where JIPR is the Ca
2z flux through IP3 receptors (IPR), JRyR the
Ca2z flux through ryanodine receptors (RyR), and JleakSR an un-
specified Ca2z leak out of the SR. We use the formulation (e.g., [30]):
Jrel~(kIPRPIPRzkRyRPRyRzJSR)(cs{c) ð9Þ
where kIPR (resp. kRyR) is the maximum rate of Ca
2z flow through
IPR (resp. RyR). Following [23], the IPR opening probability PIPR is
modelled using the Li-Rinzel/Tang et al. reduction of the De Young-
Keizer (DYK) model [34–36]:
PIPR(c,y)~
pc(1{y)
(pzK1)(czK5)
 3
, ð10Þ
where p is the IP3 concentration, and y is the fraction of inhibited
IPR. The latter obeys
dy
dt
~W1(c)(1{y){W2y, ð11Þ
with
W1(c)~k
{
2
(k42K2K1zK4p)c
K4K2(K1zp)
,
W2~k
{
2
pzk42K3
K3zp
:
ð12Þ
The parameters Ki~k
{
i =k
z
i (i~1, . . . ,4) are equilibrium
constants for IP3 and Ca
2z binding/unbinding to the IPR; we
use the original values from the DYK model [34]. The value of k{2
is scaled so that the range of ½Ca2zi oscillation frequencies matches
the experimental range, with the ratio k42~k
{
4 =k
{
2 kept constant
to the value in ref. [30] (see also Table 1). In the experiments
modelled in this work, either RyR play a negligible role, or they are
locked open by Rya-Caf treatment (see Results). Hence, we neglect
their dynamics and set the fraction of open RyR, PRyR, either to 0
or 1 depending on the experiment considered.
The Ca2z ATP-ases are modelled using the usual expressions
(e.g., [30]):
JPMCA(c)~Vp
c2
K2pzc
2
, JSERCA(c)~Ve
c2
K2ezc
2
: ð13Þ
We do not model Ca2z pumping into mitochondria explicitly,
but acknowledge that a portion of the extrusion process attributed to
PMCA might actually be performed by mitochondria uniporters, as
these might be activated at average ½Ca2zi as low as 1mM [20].
Gathering all expressions, the model is described by:
dc
dt
~a0za1pzVsPso{Vp
c2
K2pzc
2
z(kIPRPIPR(c,y)zkRyRPRyRzJSR)(cs{c){Ve
c2
K2ezc
2
,
dcs
dt
~c Ve
c2
K2ezc
2
{(kIPRPIPR(c,y)zkRyRPRyRzJSR)(cs{c)
 
,
dy
dt
~W1(c)(1{y){W2y,
dPso
dt
~ P?so (cs){Pso
 
=ts:
ð14Þ
In addition to Eq. (11), we use the following expressions to
account for the time needed by drugs to reach full effect:
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p(t)~p(1{e{t=tp ), ð15Þ
PRyR(t)~1{e
{t=tSR , ð16Þ
JSERCA(t)~Ve
c(t)2
K2ezc(t)
2
e{t=te : ð17Þ
These equations describe respectively agonist stimulation, Rya-
Caf treatment, and SERCA block by CPA (see Results).
Unless otherwise mentioned, parameter values were freely
adapted (within physiological ranges when they are known) to
account for the experimental results. The values retained are listed
in Table 1. The fitting was performed ‘‘by hand’’ (i.e., no
algorithmic method was used) within the Mathematica ‘‘Manip-
ulate’’ environment (a useful framework for fitting an ODE model
to several experimental results as it enables visualisation of the
effect of a parameter change on several ODE integrations almost
instantaneously). The code can be made freely available upon
request for academic, non-commercial use.
All simulations were run from the same initial condition as in
the experiment, which is usually the physiological equilibrium.
Bifurcation diagrams were computed using the numerical contin-
uation software AUTO [37,38].
Results
Accounting for ½Ca2zi dynamics of AMSC in lung slices
Fig. 3A-C shows representative ½Ca2zi dynamics of an ASMC
in a human lung slice in response to a three-step experimental
protocol [2]. This protocol was originally designed to clamp the
½Ca2zi of ASMC, in order to study independently the effects of
agonist and ½Ca2zi on airway contraction [28]. The slice is first
stimulated with agonist (histamine), to verify its viability (Fig. 3A).
This induces ½Ca2zi oscillations. Agonist is then washed from the
slice, and a Rya-Caf treatment is applied (Fig. 3B). This creates a
permanent Ca2z leak through RyR, because caffeine opens RyR
and ryanodine locks them open irreversibly. If this Ca2z leak is
large enough, it keeps the SR empty and prevents any further
change in ½Ca2zi, unless extracellular Ca2z is modified. The
effectiveness of the treatment is confirmed by the second
application of agonist (Fig. 3C): no further ½Ca2zi increase is
triggered, showing that ½Ca2zi is clamped. It is important to
emphasise that these results are not specific to histamine
stimulation of human lung slices: similar results have been
obtained in mouse and rat lung slices with methylcholine (Fig. 6
in ref. [29], Figs. 5B and 6C-D in ref. [28]).
Table 1. Parameter values used in the model.
Parameter symbol value units reference
PMCA maximum flux Vp 7.5 mM/s this work
PMCA affinity Kp 1.5 mM 0.1–1 [59]
SOCE maximum flux Vs 1.57 mM/s this work
STIM SR Ca2+ affinity Ks 50 mM *; c
*
s/2
SOCE Hill exponent ns 4 [33]
SOCE timescale ts 30 s [32]
Constant leak influx a0 0 mM/s %Vs
Cyt/SR vol.6buffer effects c 5.405 [34,60]
ROCE rate a1 0.00105 s
21 this work
SERCA maximum flux Ve 5 mM/s this work
SERCA affinity Ke 0.1 mM 0.1–1 [61]
CPA effect timescale te 30 s , min
IPR rate kIPR 0.667 s
21 this work
Agonist concentration p 1 mM this work
Agonist effect timescale tp 30 s , min
SR leak rate JSR 0.01 s
21 %kIPR
RyR leak rate (Rya-Caf effect) KRYR 0.19 s
22 this work
Rya-Caf effect timescale tSR 10 s , min
IPR affinity for IP3 K1 0.138 mM [34]
IPR affinity for Ca2+ (inhib. site) K2 1.05 mM [34]
IPR affinity for IP3 K3 0.943 mM [34]
IPR affinity for Ca2+ (inhib. site) K4 0.144 mM [34]
IPR affinity for Ca2+ (activ. site) K5 0.082 mM [34]
IPR Ca2+ dissoc. rate (inhib. site) k22 0.167 s
21 this work
IPR Ca2+ dissoc. rate (inhib. site) k24 0.138 k
2
2 s
21 [34]
For p~0 and kRyR~0, the equilibrium Ca
2z concentrations are c~68:1nM and cs~158mM, which are in the physiological ranges [40,41].
doi:10.1371/journal.pone.0069598.t001
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The mathematical model enables the deduction of valuable
information from the experimental results. First, from Eq. (14), the
new, elevated, ½Ca2zi equilbrium reached after Rya-Caf treat-
ment satisfies:
JPMCA(c
)~JleakinzJROCC(p)zJSOCC(cs ), ð13aÞ
JSERCA(c
)~ kIPRPIPR(c,cs )zkRyRPRyRzJSR
 
(cs{c
), ð13bÞ
where c and cs are respectively the equilibrium ½Ca2zi and
½Ca2zSR. An important consequence of (18) is that, in the absence
of SOCE, c depends only on the Ca2z fluxes through the PM.
This may seem surprising, as any increase in Ca2z flux out of the
SR (Jrel in Eq. (1)) is expected to increase ½Ca2zi. However, the
equilibrium equation (18) tells us that such an increase would only
be transient (because the PMCA pumping rate is an increasing
function of ½Ca2zi ), unless there is a concomitant permanent
increase in Ca2z influx through the PM. Hence, the persistence of
an elevated ½Ca2zi means that a permanent SOCE has been
elicited (as SOCE is the only Ca2z influx capable of increase upon
Rya-Caf treatment). Moreover, the model indicates that ROCE is
negligible after Rya-Caf treatment. Indeed, if it was not, the
addition of agonist would increase c via the increase in JROCC .
Hence, we assume that the ROCE rate a1 is small (see Table 1 and
Discussion).
Results of ‘‘hand-fitting’’ the model to the experimental results
are shown in Figs. 3D–F and Fig. 4, with the corresponding
parameter values listed in Table 1. The model reproduces (i) the
agonist-induced Ca2z oscillations, (ii) the similar magnitudes of
the new equilibrium ½Ca2zi in Fig. 3B and the amplitude of the
oscillations in Fig. 3A, and (iii) the negligible effect of agonist
stimulation after Rya-Caf treatment. Agonist-induced Ca2z
oscillations were simulated with PRyR~0 because RyR appear
to play a negligible role during agonist-induced Ca2z oscillations
[2,39]. On the other hand, the response to Rya-Caf was simulated
with PRyR~1 since the treatment locks open the RyR. We did not
attempt to reproduce the magnitude of the initial spike response to
Rya-Caf treatment relative to that of the subsequent ½Ca2zi
plateau (Fig. 3B) because the fluorescent dye used in the
experiments saturates rapidly with ½Ca2zi. Parameter values
were also adjusted to yield physiological Ca2z equilibrium
concentrations (c*0:1mM [40] and cs*500mM [41]), realistic
½Ca2zi oscillation amplitude (*; 1mM), and to reproduce the
range of ½Ca2zi oscillation frequencies observed in human
lung slices as a function of agonist (0.5–11/min [2]). More detail
Figure 3. ½Ca2zi dynamics in ASMC: experiment and model. (A)–(C): Fluorescence imaging of ½Ca2zi dynamics in an ASMC within a human
lung slice, during the following 3-step experiment: (A) Agonist stimulation, (B) Rya-Caf treatment, and (C) second agonist stimulation. Following the
irreversible Rya-Caf treatment in (B), agonist stimulation (C) is no longer able to elicit Ca2z oscillations, nor does it perturb the new elevated ½Ca2zi
equilibrium. Reprinted from [2] under a CC BY license, with permission of the American Thoracic Society, original copyright 2010. Cite: Ressmeyer et al. /
2010/Am J Respir Cell Mol Biol/43/179–191. Official journal of the American Thoracic Society. This modified figure is based on the original figure available
from www.atsjournals.org. (D)–(F): Simulations of the experiments in (A)–(C) using Eqs. 114–12 and the parameter values in Table 1. The evolution of
½Ca2zi , ½Ca2zSR , and Pso (fraction of open SOCC) are shown (cf. legend in (E)).
doi:10.1371/journal.pone.0069598.g003
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on the parameter estimation procedure is given in Supporting
Information S1.
Fig. 4 shows the bifurcation diagram of the model as a func-
tion of agonist concentration. Periodic solutions (i.e., Ca2z
oscillations) arise through a Hopf bifurcation, and disappear
through a saddle-node bifurcation of limit cycles. A second Hopf
bifurcation is present on the steady-state branch, and is associated
with a region of bistability between the steady-state and the
periodic solution at the right of the bifurcation diagram. It is
not known whether such bistability occurs in reality. It should
also be noted that the steady-state ½Ca2zi increases with
agonist concentration, as is expected (e.g., [30]). This increase is
provided by SOCE in our model. Indeed, the Ca2z flux through
IPR increases with agonist, so that store depletion increases as
well.
Effect of SOCE regulation on agonist-induced Ca2z
oscillations
SOCE is the main Ca2z influx in the model, as ROCE is
negligible (see above) and the Ca2z leak influx is (by definition)
small. Fig. 3D shows that while SOCE is almost zero at
physiological equilibrium (initial condition), it substantially in-
creases during agonist-induced Ca2z oscillations (final condition;
see also Fig. 4), due to significant SR Ca2z depletion. Therefore,
changes in SOCE can be expected to have a substantial effect on
Ca2z oscillations. This is quantified in Fig. 5, where the amplitude
and frequency of Ca2z oscillations are plotted as a function of (a)
the maximum SOCE rate, Vs, and (b) STIM affinity for Ca
2z, Ks
(the ½Ca2zSR at which half SOCC are open). It is found that the
½Ca2zi oscillation frequency varies as much with Vs and Ks at
fixed agonist concentration (Fig. 5) as it varies with agonist
concentration at fixed SOCE parameters (Fig. 4). Moreover, a too
big departure from the ‘‘normal’’ values (dotted lines, Table 1)
leads to the extinction of the Ca2z oscillations (via a Hopf
bifurcation to the left, and a saddle-node to the right, of the
bifurcation diagrams in Figs. 5A–B). These results are not very
surprising to the extent that Ca2z oscillations are expected to
depend crucially on Ca2z influx (e.g., [42]). However, they
suggest that SOCE could play a role in AHR since (i) ½Ca2zi
oscillations mediate ASMC contraction, and (ii) SOCE up-
regulation (which increases ½Ca2zi oscillation frequency) can be
triggered by inflammatory mediators commonly found in asthma
[9,11,24].
Partial inhibition of SERCA by CPA
We now apply the model to experimental data from mouse lung
slices showing an attempt to clamp ½Ca2zi with the SERCA
blocker CPA, instead of Rya-Caf treatment (Fig. 6). After inducing
Ca2z oscillations with agonist, CPA is applied in the presence of
agonist (for faster emptying of the SR than CPA alone) and causes
a gradual damping of the Ca2z oscillations, together with a rise of
the ½Ca2zi baseline, until the oscillations become undistinguish-
able from fluctuations around an elevated steady ½Ca2zi mean.
Because CPA is believed to inhibit SERCA, the assumption, at this
stage of the experiment, is that the SR is empty and SOCE fully
Figure 4. Ca2zdynamics as a function of agonist concentration.
Dashed curves represent steady-states (constant Ca2z levels); solid
curves, periodic solutions (Ca2z oscillations). The maximum ½Ca2zi
(black) and the maximum fraction of open SOCC (blue) during one
solution period are plotted as ordinates. The red curve (right y-axis)
shows the frequency of the Ca2z oscillations on the main stable
segment (from the upper blue dot to the black cross), which fits the
experimental range in human [2]. The stable solutions are represented
as thick lines and unstable solutions as thin lines. The green diamonds
represent Hopf bifurcations, the black cross, a saddle-node bifurcation,
and the blue dots, period-doubling points. Period-doubled branches
are not shown because they extend only over a tiny range of p values;
moreover it is likely that the deterministic description of Ca2z
oscillations fails at these low agonist concentrations (see Discussion).
The vertical dotted line indicates the value of p used in Fig. 3 (Table 1).
doi:10.1371/journal.pone.0069598.g004
Figure 5. Influence of SOCE on agonist-induced½Ca2zioscillations. Amplitude (black) and frequency (red) of Ca2z oscillations as a function
of (A) SOCE maximum rate, Vs , and (B) STIM affinity for SR Ca
2z, Ks. Dotted lines indicate the ‘‘normal’’ parameter values (Table 1, Figs. 3D–F). As in
Fig. 4, only the frequency of the large-amplitude stable Ca2z oscillations is shown.
doi:10.1371/journal.pone.0069598.g005
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active. However, when agonist is removed (CPA remains), ½Ca2zi
falls. When agonist is reapplied, ½Ca2zi increases. These ½Ca2zi
responses to agonist addition and removal are not observed when
SOCE is evoked by Rya-Caf treatment. According to our model
(Eq.(18)), the decrease in ½Ca2zi upon agonist removal indicates
that SOCE does not remain activated, i.e. that the SR refills with
Ca2z. This suggests that the SERCA are not completely blocked
by CPA, as illustrated by the simulations in Fig. 6B–D. If CPA was
to fully block the SERCA (Fig. 6B), ½Ca2zi would not decrease
upon agonist removal. If ½Ca2zi falls, it must be because either
CPA requires a longer time than that used in the experiment to
fully block the SERCA (Fig. 6C), or CPA achieves only partial
block of the SERCA (Fig. 6D).
Experiments of longer duration were performed to test the
model predictions. Fig. 7A shows that if CPA is applied in the
presence of agonist for 5 minutes, followed by CPA only for a
further 10 minutes, ½Ca2zi still returns to the original equilibrium
level when agonist is removed, and remains low until agonist is
reintroduced. This suggests that the explanation in Fig. 6C can be
rejected, otherwise the longer exposure to CPA should yield a
result similar to Fig. 6B. The inability of CPA to fully empty the
SR of Ca2z is confirmed by Fig. 7B, where extracellular calcium is
removed before agonist is applied a second time, to prevent any
potential ROCE. The Ca2z response induced can thus be
unambiguously attributed to Ca2z release from the SR.
Hence, our combined modelling and experimental study
indicates that CPA blocks only partially the SERCA of ASMC
in lung slices (scenario simulated in Fig. 6D). This is a potentially
important result given the wide use of CPA in cell biology to study
SOCE. We note that Figs. 6A and 7 could also be explained by a
model assuming that ROCE, instead of SOCE, is the main Ca2z
influx (e.g., [23]). However, such a model would fail to explain the
outcome of Rya-Caf treatment in human and mouse lung slices
(both the persistent elevated ½Ca2zi in the absence of agonist, and
the absence of effect of agonist on this elevated ½Ca2zi ). In
contrast, our model, constructed to account for both agonist-
induced oscillations and Rya-Caf treatment, explains the CPA
results without requiring any modification. Its prediction holds
provided CPA is not a 100% efficient SERCA blocker, and this
hypothesis is supported by the experimental data in Fig. 7.
Discussion
Modelling SOCE
Our mathematical model accounts for the two main properties
of SOCE: 1) SOCE is an increasing function of Ca2z store
depletion, and 2) it activates slowly upon store depletion. While the
mechanisms of SOCE activation are rather well understood
[14,32], the mechanisms of SOCE termination remain less clear
[43,44]. Hence, we do not explicitly distinguish between SOCE
activation and inactivation in the model, and use a single
parameter Ks for STIM affinity for SR Ca
2z and a single time
constant ts for the slow adaptation to changes in ½Ca2zSR. This is
also justified by the fact that most experimental data available on
Figure 6. Effect of CPA on½Ca2zi dynamics. (A) Fluorescence imaging of ½Ca2zi in ASMC of a mouse lung slice treated with agonist and CPA.
Agonist removal leads to ½Ca2zi decrease. (B–D) Model simulations of the experiments shown in (A), assuming that (B) CPA quickly blocks the
SERCA, (C) CPA slowly blocks the SERCA, (D) CPA partially blocks the SERCA but reaches maximum strength rather quickly. Black solid and dashed
curves (left y-axis) represent respectively ½Ca2zi and ½Ca2zSR ; blue and red curves (right y-axis) show respectively the fraction of open SOCC and
the fraction of operating SERCA (that is, PSERCA~JSERCA=Ve , where JSERCA is given by Eq. (0c)).
doi:10.1371/journal.pone.0069598.g006
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SOCE come from a category of SOCC called CRACC (Ca2z -
release-activated Ca2z channels), which are highly selective to
Ca2z, while there is evidence that SOCE in ASMC (and in other
cells) occurs at least in part through non-selective Ca2z channels
(NSCC). It could be that the latter operate somewhat differently
from CRACC in response to store depletion or refilling.
Our description of SOCE slow activation upon store depletion
is continuous, which is easy to handle computationally, and
compatible with experimental knowledge. Indeed, it is reasonable
to assume that a small fraction of STIM proteins reside in close
proximity to the PM, and may thus bind Orai quickly upon store
depletion. Hence, a weak SOCE is likely to occur almost
instantaneously upon store depletion, rendering unnecessary to
introduce a finite activation delay in the model via a delay-
differential equation.
We are aware of only few prior works on Ca2z dynamics that
include a mathematical description of SOCE, all of which are
ODE models [15–18]. The first two were published before the
molecular basis for SOCE was established. The latter two works
Figure 7. Experimental evidence that CPA does not fully empty the SR of ASMC. Tests of the model predictions shown in Fig. 6B–D,
performed with mouse lung slices. (A) Significantly longer exposure to agonist+CPA and to CPA than in Fig. 6A still fails to maintain SOCE. (B) Same
experiment as in (A) except that extracellular Ca2z is removed before agonist is applied a second time, confirming the residual presence of Ca2z in
the SR and hence the partial efficacy of CPA to inhibit SERCA (scenario of Fig. 6D). (Insets show magnifications of selected time windows).
doi:10.1371/journal.pone.0069598.g007
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include more realistic descriptions of SOCE, but none of them
accounts for the slow translocation of oligomerised STIM to the
PM, while it is recognised as the rate-limiting event for SOCE
activation [32]. Ong et al. however assume a slow diffusion of
Ca2z between internal SR and superficial SR (modelled as distinct
compartments exchanging Ca2z ), with SOCE being triggered by
peripheral SR depletion [17]. Liu et al. explicitly model both SR
Ca2z dissociation from STIM and binding of STIM to Orai. Both
models are used to study transient ½Ca2zi responses only; ½Ca2zi
oscillations are not considered. Prior models of Ca2z dynamics
specific to ASMC did not include SOCE, while we have shown
that this is necessary to account for several experimental results
obtained with lung slices. The work of Haberichter et al. [19]
focused on the influence of the different IPR isoforms on Ca2z
signalling in ASMC. Brumen et al. studied the influence of the total
Ca2z content on the nature (damped or sustained) and frequency
of agonist-induced Ca2z oscillations [21]. Roux et al. did not
model Ca2z oscillations, but transient Ca2z responses to caffeine
[20]. Finally, the model by Wang et al. [23] addressed the different
contributions of IPR and RyR to agonist-induced and KCl-
induced Ca2z oscillations in ASMC.
From the mathematical point of view, the fact that SOCE is an
explicit function of store Ca2z renders the models of Ca2z
dynamics including this influx qualitatively different from those
which do not, as SOCE couples the homogenous steady-state
½Ca2zi to ½Ca2zSR (Eq. (18)). This property is essential for the
predictions of our model (in particular, the persistence of an
elevated ½Ca2zi upon sustained store depletion in the absence of
agonist). On the other hand, whether SOCE is an instantaneous or
delayed function of ½Ca2zSR appears to have little effect on our
results.
SOCE vs. ROCE
While Fig. 3C (as well as Fig. 6 in ref. [29], Figs. 5B and 6C-D
in ref. [28]) shows that no ROCE is elicited by agonist following
Rya-Caf treatment, it does not imply that ROCE cannot play a
substantial role during other, more physiological, conditions, such
as agonist-induced Ca2z oscillations. It could be that ROCE is
inhibited at the large ½Ca2zi levels induced by SOCE activation
following Rya-Caf treatment. Instead of assuming the existence of
an inactivation process at large ½Ca2zi, we assumed, for
simplicity, that ROCE is negligible in the model. This approach
enabled us to show that Ca2z influx through SOCC is sufficient to
sustain agonist-induced ½Ca2zi oscillations, and to explain the
experimental results obtained with CPA, although the latter could
be interpreted as evidence for ROCE at first sight. The fact that
there appears to be no selective blocker for SOCE and ROCE
makes it difficult to evaluate experimentally the respective
contributions of the two Ca2z influxes during physiological
conditions. These magnitudes are probably also cell-type depen-
dent. Such issues explain the persistence of the controversy
regarding SOCE and ROCE [45–48]. An informative experiment
would be to stimulate ASMC using flash photolysis of caged IP3
instead of agonist stimulation. Indeed, as IP3 does not induce
ROCE, SOCE should be the essential Ca2z influx left. By
comparing the responses to IP3 stimulation in the presence and in
the absence of extracellular calcium, one could then deduce the
importance of SOCE in physiological conditions.
Efficacy of CPA
CPA is widely used as a SERCA blocker, having the advantage
over Thapsigargin (Tg) of being reversible, and probably less toxic.
Both have been used extensively to study SOCE in different cell
types (e.g., [25–27,43,49]). Although our work indicates that CPA
does not fully block the SERCA in intact tissue such as lung slices,
it does not imply that CPA should not be used experimentally to
induce SOCE. Indeed, CPA might still cause substantial SOCE
activation in the presence of agonist. However, our results indicate
that CPA is not a good mean to fully empty Ca2z stores, and care
should be taken in interpreting the experimental results of its
application. We suggest that a combined Rya-Caf treatment is a
more reliable way to induce a permanent large SR depletion
(Fig. 3B, C). There is evidence that Tg is an efficient SERCA
blocker in cell lines such as Hela cells [43], but we have not
addressed the effect of Tg on ASMC in lung slices in this study.
Modelling IPR
In this work, we followed the approach of Wang et al. [23], in
that we have used one of the simplest models of IPR Ca2z release,
namely the Li-Rinzel/Tang et al. reduction of the DYK ODE
model [34–36]. This category of IPR model produces agonist-
induced Ca2z oscillations characterised by significant SR Ca2z
depletion (Fig. 3D and [23]), hence the possibility of SOCE being
activated during such Ca2z oscillations. This property might be
model-dependent, however there is evidence that the SR is
actually depleted to some extent during agonist-induced Ca2z
oscillations in ASMC. Indeed, the absence of effect of ryanodine
during agonist-induced oscillations can be explained by the
average level of ½Ca2zSR being too low for RyR activation
[1,23]. However, the respective ½Ca2zSR ‘‘thresholds’’ for SOCE
and RyR activation are experimentally unknown. In this work, the
SOCE activation threshold was deduced from fitting the model
simultaneously to Fig. 3A and Figs. 3B–C.
Finally, we note that our whole-cell ½Ca2zi model would likely
not benefit from using a recent Markov model of an IPR (e.g.,
[50–52]), because these models are based on steady-state data only
(i.e., single-channel opening and closing times in stationary Ca2z
and IP3) and typically miss the long inactivation timescale which
was included ‘‘ad hoc’’ in the first IPR models to reproduce the
observed behavior at the cell level (i.e., ½Ca2zi oscillations upon
agonist stimulation).
Limitations of the whole-cell model
As we are essentially interested in ½Ca2zi responses of ASMC
at the cell level, we have described Ca2z dynamics via a
deterministic ODE model. The scope of this model is, however,
somewhat limited for the following reasons.
First, there is evidence that IPR are not homogeneously
distributed on the SR membrane of cells, but are found as dense
clusters. This channel clustering is especially patent upon
stimulation by low agonist concentrations, for which local,
stochastic Ca2z releases may not propagate to neighboring
clusters, resulting in spatially isolated, unsynchronised Ca2z
releases, called ‘‘puffs’’. At higher agonist concentrations, the
frequency of these puffs increases, allowing Ca2z releases from
close sites to accumulate and propagate further away. This
triggers, via CICR, the firing of more distant clusters, and results
in Ca2z waves propagating repeatedly throughout the cytosol.
These waves usually appear as Ca2z oscillations at the whole-cell
level. While Ca2z waves are indeed associated with ½Ca2zi
oscillations in ASMC [1], it has, so far, been impossible to detect
Ca2z puffs. This could arise from a less clustered distribution of
IPR in ASMC, compared to the larger cells (ooycytes and Hela
cells) where puffs have been characterised. On the other hand,
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Ca2z ‘‘sparks’’, the equivalent of Ca2z puffs but mediated by
RyR, have been detected in ASMC [1], which supports a clustered
distribution of RyR. In this study, we did not attempt to consider
these spatial/stochastic aspects of the Ca2z signals. Our model is
thus less reliable at low agonist concentrations.
Second, cytoplasmic microdomains often exist between cell
organelles (e.g., between peripheral SR and the plasma mem-
brane, between the SR and mitochondria), out of which ½Ca2zi
cannot diffuse easily. These have consequences for SOCE
dynamics. Indeed, it has been reported that upon store depletion,
SERCA can colocalise with STIM proteins, in proximity to the
PM [49,53]. As a consequence, if SOCE is slow enough, the SR
can refill with Ca2z without a concomitant increase in bulk
½Ca2zi [49]. Upon large SOCE, this is no longer the case;
however, mitochondria prevent the local Ca2z increase to become
too large by pumping Ca2z from the subplasmalemmal space and
releasing it deeper in the cytoplasm, where it can be absorbed by
other SERCA [49]. These spatial effects cannot be accounted for
by our current non-compartmentalised model.
Finally, Ca2z dynamics are modified by Ca2z buffers in the
cytosol and SR, which bind 99% of the free Ca2z. While the effect
of fast, linear buffers can be taken into account by a global
rescaling of Ca2z fluxes (see Methods), this is not the case for high
affinity buffers, in particular fluorescent dye indicators. Including
such buffers in an ODE model of ½Ca2zi dynamics leads to
suppression of ½Ca2zi oscillations, because the buffer affinity is
close to the amplitude of whole-cell ½Ca2zi oscillations. In reality,
½Ca2zi reaches much higher levels locally upon IPR opening, so
that the buffers become saturated and cannot prevent Ca2z
oscillations. Again, this would have to be accounted for by a spatial
model of Ca2z dynamics.
Future work
Although RyR dynamics play a role only during the initial
phases of agonist-induced Ca2z oscillations and Rya-Caf treat-
ment, the interaction between RyR and IPR may become
important in other situations, such as drug-induced RyR
sensitisation. We plan to extend our model to these dynamics.
Since our work is part of a broader effort to improve the
understanding of airway hyper-responsiveness and remodelling via
mathematical modelling [54–57], we also intent to model the
interaction of ASMC Ca2z signalling with other aspects of lung
dynamics. Although mathematical models of ASM contraction
have previously been developed [54,55,58], modelling of other
signalling pathways, such as inflammation and proliferation, is, to
our knowledge, still in its infancy.
Additionally, experimental studies of ASMC inflammation and
proliferation in conjunction with ½Ca2zi imaging in lung slices
would be desirable. While such studies have been carried out with
cultured ASMC [3–5,9–12], they do not provide individual
½Ca2zi dynamics; moreover, cultured ASMC often exhibit a
different phenotype from ASMC in intact tissues.
Conclusions
The inclusion of SOCE in our mathematical model of Ca2z
dynamics in ASMC enables a better understanding of the
experimental physiology of lung slices. It shows that the different
abilities of CPA and Rya-Caf treatment to clamp the ½Ca2zi of
ASMC can be explained by their different ability to invoke SOCE.
The model predicts that CPA, in contrast with Rya-Caf treatment,
is unable to empty the SR because of its inefficiency to fully inhibit
the SERCA. Furthermore, by accounting for both agonist-induced
Ca2z oscillations and SOCE activation by SR Ca2z depletion,
the model shows that SOCE can be a major determinant of the
frequency of agonist-induced Ca2z oscillations. Because this
frequency of the Ca2z oscillations regulates airway contraction,
the model suggests a role for increased SOCE in AHR, a
correlation consistent with SOCE up-regulation under inflamma-
tory conditions typical of asthma. These predictions underscore
the synergistic role for mathematical modeling in medical
research.
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